Stay updated on Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.

Latest updates to the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA site-wide NIH announcement about terminology and website updates appears above the page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check16 days agoChange DetectedThe site revision label in the footer was updated from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. This indicates access to the study information is restricted, rather than a substantive update to the page content.SummaryDifference18%

- Check44 days agoChange DetectedThe page's revision tag advanced from v3.6.6 to v3.7.0, indicating a system or template update. This update does not alter any study details or visible information on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision tag was updated to v3.6.6, replacing v3.6.5, indicating a small update to the page's content or formatting.SummaryDifference0.0%

- Check65 days agoChange DetectedA new entry '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH support for the trial.SummaryDifference0.0%

Stay in the know with updates to Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.